We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+11.14%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$468M
AUM Growth
+$67.5M
Cap. Flow
+$29.5M
Cap. Flow %
6.31%
Top 10 Hldgs %
41.39%
Holding
86
New
11
Increased
45
Reduced
11
Closed
5

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.16M
2
UNP icon
Union Pacific
UNP
+$2.12M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.93M
4
LLY icon
Eli Lilly
LLY
+$1.81M
5
AMZN icon
Amazon
AMZN
+$1.73M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.01M
2
CHD icon
Church & Dwight Co
CHD
+$2.72M
3
NVDA icon
NVIDIA
NVDA
+$1.04M
4
AMD icon
Advanced Micro Devices
AMD
+$767K
5
EW icon
Edwards Lifesciences
EW
+$767K

Sector Composition

Rank Sector Weight
1 Technology 30.7%
2 Healthcare 17.79%
3 Industrials 12.47%
4 Consumer Discretionary 9.58%
5 Communication Services 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
76
McDonald's
MCD
$190B
-675
Closed -$200K

Similar funds

Brian C. Broderick's Q1 2024 Portfolio in Review

As of Q1 2024, Brian C. Broderick held 86 positions worth $468M, up 17% from $401M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Brian C. Broderick deployed $29.5M of net new capital in Q1 2024, opening 11 new positions and adding to 45 existing holdings. Its largest new stake was Eli Lilly: 2,545 shares worth $1.98M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was NVIDIA, an estimated $1.04M trimmed.

  • Brian C. Broderick's largest Q1 2024 buy was Eli Lilly: 2,545 shares worth $1.98M.
  • Brian C. Broderick added most to Procter & Gamble in Q1 2024, an estimated $2.16M increase.
  • Brian C. Broderick's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.04M.
  • Brian C. Broderick fully exited CVS Health in Q1 2024, selling an estimated $3.01M.
  • Brian C. Broderick's ten largest holdings make up 41% of its $468M portfolio in Q1 2024.
  • Brian C. Broderick opened 11 new positions and closed 5 in Q1 2024.
  • Brian C. Broderick's portfolio value rose 17% quarter-over-quarter to $468M.

Based on Brian C. Broderick's 13F filing for Q1 2024, filed 6 May 2024.